The IPO Buzz: Generate Biomedicines (GENB Proposed) Launches $400 Million IPO

Generate Biomedicines, Inc. (GENB Proposed), a clinical biology company developing a treatment for severe asthma, launched its $400 million IPO early today – Monday, Feb. 23, 2026 – for pricing later this week. (Please see the IPO Calendar for the pricing date.) In its S-1/A filing, Generate Biomedicines disclosed the IPO’s terms – 25 million […]

February 23, 2026 Read More

The IPO Buzz: Armada Acquisition Corp. III Raises $225 Million in SPAC IPO

FinTech-focused Armada Acquisition Corp. III (AACIU) priced its SPAC IPO on Tuesday night, Feb. 17, 2026, and raised $225 million – as expected. Armada Acquisition III’s SPAC IPO consisted of 22.5 million units at $10.00 each. Armada Acquisition Corp. III (AACIU) slipped in its NASDAQ debut today – Wednesday, Feb. 18, 2026 – opening at […]

February 17, 2026 Read More

The IPO Buzz: Japan’s PayPay (PAYP Proposed) May Be the Next Big Deal

SoftBank-backed PayPay (PAYP Proposed) of Japan may become the next big IPO. PayPay, the dominant QR code mobile app in Japan, filed to go public last week. (No terms yet.) This could be the biggest Japanese IPO ever done in the U.S., according to Bloomberg. Some think that PayPay’s IPO could raise as much as […]

February 16, 2026 Read More

The IPO Buzz: Spring Valley Acquisition IV Raises $200 Million

Spring Valley Acquisition Corp. IV (SVIVU) raised $200 million with the pricing of its SPAC IPO on Monday night, Feb. 9, 2026. The deal – 20 million units at $10.00 each – was priced in sync with the terms in the prospectus. Spring Valley Acquisition IV opened at $10.06 at 10:52 a.m. EST today – […]

Read More